Posted by Stacy Theobald (@stacytheobald) · Nov 10, 2011
Rare treatment for rare disease: Triple transplant
On June 14, 2011, after a 107-day wait in the hospital at Mayo Clinic in Rochester, Minn., Kirk Watson, 44, received the news he’d been waiting for — a heart, liver and kidney were available for him.
He would be the fourth person to receive a triple transplant at Mayo Clinic and only the 11th in the United States.
The organs for transplant didn’t arrive without a glitch. A storm delayed their arrival via plane for a few hours. Watson and his wife, Rita, watched the thunder and lightning from the window of the hospital room while they waited.
“It was magnificent. Mother Nature put on quite a show,” says Watson, who lives in Westminster, Colo. “This great display in the sky seemed parallel to the frenzy of activity going on in the operating room to prepare for my surgery. All we could do was remain calm, enjoy the time together and continue to wait until it was time.”
Watson went into the operating room at midnight. Halfway through the next day, his surgery was complete.
Watson has hereditary amyloidosis, a relatively rare blood disease that develops when protein builds up in organs and tissues. Affected areas can include the heart, liver, kidneys, spleen, digestive tract and nervous system. Hereditary amyloidosis often is not diagnosed until significant organ damage has occurred. The symptoms can be confused with other conditions.
Watson first had symptoms in 2002. He was exhausted and had inexplicably gained 30 pounds. He was diagnosed with a viral heart condition and told he would need a heart transplant. For several years, he says his physicians in Colorado were able to maintain but not improve his condition with medication. In the last few years, Watson’s day-to-day activities had become significantly limited. He’d had to quit working as a deputy sheriff in Boulder, Colo.
In 2008, a DNA test confirmed Watson had hereditary amyloidosis. His aunt was diagnosed with the disease at about the same time. She was one of the previous triple transplant patients at Mayo Clinic.
“Not many doctors around the country know much about our disease, so my doctors referred me to Mayo Clinic, too,” says Watson. “I was evaluated at Mayo in January 2010 and returned in October to wait for a transplant. By that time, I was pretty depleted. My energy was nonexistent, and I’d been fainting. I knew I wouldn’t be leaving Minnesota unless I received a transplant.”
Watson remained in the hospital for 12 days immediately after the transplant and in Rochester at the Gift of Life Transplant House for several months, post-transplant having cardiac rehabilitation three times a week.
“I can feel my body rejuvenating,” he says. “Before my surgery, my extremities were blue-tinged due to poor blood flow. Now, they’re pink like they should be.” He expects to return to normal activities within 12 to 18 months.
“I’m grateful for the organ donation,” he says. “It’s a selfless act for the donor and his family.”
At least 10 other members of Watson’s extended family also have been diagnosed with hereditary amyloidosis. Whether the disease will require treatment or transplant remains to be seen.
“Mayo seems to be the place with expertise in hereditary amyloidosis,” says Watson. “They helped my aunt, they helped me, and I’ve met other people at Mayo who are getting help. I’m confident that will continue to be the case.”
(This story comes to us from the Sharing Mayo Clinic print publication.)